Journal • Tumor mutational burden • Microsatellite instability • MSi-H Biomarker • PD(L)-1 Biomarker
|
PD-L1 (Programmed death ligand 1) • ALK (Anaplastic lymphoma kinase) • TP53 (Tumor protein P53) • TMB (Tumor Mutational Burden) • MSI (Microsatellite instability) • EML4 (EMAP Like 4) • STK11 (Serine/threonine kinase 11) • MLH1 (MutL homolog 1)
|
PD-L1 expression • TP53 mutation • TMB-H • MSI-H/dMMR • ALK positive • ALK rearrangement • STK11 mutation • ALK fusion
|
Avastin (bevacizumab) • cisplatin • carboplatin • Focus V (anlotinib) • Tyvyt (sintilimab) • Alecensa (alectinib) • Lorbrena (lorlatinib) • albumin-bound paclitaxel • pemetrexed • Qi Xinke (iruplinalkib)